{
  "id": 1767780773102,
  "title": "Phakomatoses: A Clinical Masterguide",
  "summary": "An exhaustive visual overview of the phakomatoses—a complex group of conditions characterized by neurological, ocular, and cutaneous features with a predisposition for hamartomatous tumors. This guide covers the archetypal syndromes and vascular variants from Chapter 18 of Paediatric Ophthalmology.",
  "date": "2026-01-07T10:12:53.102Z",
  "data": {
    "title": "Phakomatoses: A Clinical Masterguide",
    "summary": "An exhaustive visual overview of the phakomatoses—a complex group of conditions characterized by neurological, ocular, and cutaneous features with a predisposition for hamartomatous tumors. This guide covers the archetypal syndromes and vascular variants from Chapter 18 of Paediatric Ophthalmology.",
    "summary_illustration": "<svg viewBox='0 0 200 200' xmlns='http://www.w3.org/2000/svg'><circle cx='100' cy='100' r='80' fill='none' stroke='hsl(215, 90%, 45%)' stroke-width='4'/><path d='M60 100 Q100 40 140 100 Q100 160 60 100' fill='none' stroke='hsl(215, 90%, 45%)' stroke-width='4'/><circle cx='100' cy='100' r='20' fill='hsl(215, 90%, 45%)'/><path d='M40 40 L60 60 M140 40 L160 60 M40 160 L60 140 M140 160 L160 140' stroke='hsl(215, 90%, 45%)' stroke-width='3' stroke-linecap='round'/></svg>",
    "sections": [
      {
        "title": "Introduction to Phakomatoses",
        "icon": "info",
        "type": "plain_text",
        "layout": "full_width",
        "color_theme": "blue",
        "content": "The phakomatoses are a group of conditions with neurological, ocular, and cutaneous features, and a tendency to develop tumours, usually of a hamartomatous type. There is considerable debate about which conditions to include, but neurofibromatosis, tuberous sclerosis, and VhL syndrome are generally considered to be the archetypes."
      },
      {
        "title": "Neurofibromatosis: Genetics & Prevalence",
        "icon": "dna",
        "type": "table",
        "layout": "half_width",
        "color_theme": "purple",
        "content": {
          "headers": [
            "Feature",
            "NF-1",
            "NF-2"
          ],
          "rows": [
            [
              "Prevalence",
              "1/3,000 (Commonest)",
              "1/25,000 (Much less common)"
            ],
            [
              "Gene Mutation",
              "Neurofibromin gene",
              "Merlin gene"
            ],
            [
              "Chromosome",
              "Chr 17q",
              "Chr 22q"
            ],
            [
              "Inheritance",
              "Autosomal Dominant (AD)",
              "Autosomal Dominant (AD)"
            ],
            [
              "Expressivity",
              "Variable",
              "Variable"
            ]
          ]
        }
      },
      {
        "title": "Table 18.47: Features of NF-1",
        "icon": "visibility",
        "type": "table",
        "layout": "full_width",
        "color_theme": "green",
        "content": {
          "headers": [
            "Ocular Features",
            "Systemic Features"
          ],
          "rows": [
            [
              "Optic nerve glioma*",
              "Café-au-lait spots (≥6; each >0.5cm pre-puberty or >1.5cm post-puberty)*"
            ],
            [
              "Lisch nodules (≥2)*",
              "Axillary/inguinal freckling*"
            ],
            [
              "Lid neurofibroma",
              "Neurofibromas (≥1 plexiform type or ≥2 any type)*"
            ],
            [
              "Choroidal naevi",
              "Characteristic bony lesion (sphenoid dysplasia, which may cause pulsatile proptosis; long bone cortex thinning/dysplasia)*"
            ],
            [
              "Retinal astrocytoma",
              "First-degree relative with NF-1*"
            ]
          ]
        }
      },
      {
        "title": "NF-1 Diagnostic Requirement",
        "icon": "rule",
        "type": "key_point",
        "layout": "half_width",
        "color_theme": "yellow",
        "content": [
          "Diagnosis requires two or more of the features marked with an * in Table 18.47."
        ]
      },
      {
        "title": "Table 18.48: Features of NF-2",
        "icon": "hearing",
        "type": "table",
        "layout": "full_width",
        "color_theme": "green",
        "content": {
          "headers": [
            "Ocular Features",
            "Systemic Features"
          ],
          "rows": [
            [
              "Early-onset posterior subcapsular or cortical cataracts",
              "Acoustic neuroma (AN)"
            ],
            [
              "Combined hamartoma of RPE and retina",
              "Meningioma"
            ],
            [
              "",
              "Glioma"
            ],
            [
              "",
              "Schwannoma"
            ],
            [
              "",
              "First-degree relative with NF-2"
            ]
          ]
        }
      },
      {
        "title": "NF-2 Diagnostic Criteria",
        "icon": "fact_check",
        "type": "key_point",
        "layout": "full_width",
        "color_theme": "purple",
        "content": [
          "Definite NF-2: bilateral AN OR first-degree relative with NF-2 AND either unilateral AN (at <30y) or any two of meningioma, glioma, schwannoma, or juvenile cataract.",
          "Probable NF-2: unilateral AN (<30y) AND one of meningioma, glioma, schwannoma, or juvenile cataract; OR multiple meningiomas AND unilateral AN (<30y) or one of meningioma, glioma, schwannoma, or juvenile cataract."
        ]
      },
      {
        "title": "Tuberous Sclerosis (TSC)",
        "icon": "psychology",
        "type": "mindmap",
        "layout": "full_width",
        "color_theme": "yellow",
        "content": {
          "center": "Tuberous Sclerosis (1/6,000)",
          "branches": [
            "Inheritance: AD with variable expressivity",
            "50% cases from new mutations",
            "TSC1 (Chr 9q) codes for hamartin",
            "TSC2 (Chr 16p) codes for tuberin"
          ]
        }
      },
      {
        "title": "Table 18.49: Features of Tuberous Sclerosis",
        "icon": "list_alt",
        "type": "table",
        "layout": "full_width",
        "color_theme": "green",
        "content": {
          "headers": [
            "Ocular Features",
            "Systemic Features"
          ],
          "rows": [
            [
              "Retinal astrocytoma",
              "Adenoma sebaceum"
            ],
            [
              "",
              "Ash leaf spots"
            ],
            [
              "",
              "Shagreen patches"
            ],
            [
              "",
              "Subungual fibromas"
            ],
            [
              "",
              "Cerebral astrocytomas (with epilepsy and dIQ)"
            ],
            [
              "",
              "Visceral hamartomas (e.g. renal angiomyolipoma, cardiac rhabdomyoma)"
            ],
            [
              "",
              "Visceral cysts"
            ],
            [
              "",
              "Pulmonary lymphangioleiomyomatosis"
            ]
          ]
        }
      },
      {
        "title": "VhL Syndrome",
        "icon": "biotech",
        "type": "key_point",
        "layout": "half_width",
        "color_theme": "red",
        "content": [
          "Rare condition (Prevalence 1/36,000)",
          "Arises from mutations in the VHL gene (Chr 3p)",
          "Involved in vascular proliferation",
          "Inheritance: Autosomal Dominant (AD)"
        ]
      },
      {
        "title": "Table 18.50: Features of VhL Syndrome",
        "icon": "medical_services",
        "type": "table",
        "layout": "full_width",
        "color_theme": "red",
        "content": {
          "headers": [
            "Ocular Features",
            "Systemic Features"
          ],
          "rows": [
            [
              "Retinal capillary haemangioma",
              "Haemangioblastoma of cerebellum, spinal cord, or brainstem"
            ],
            [
              "",
              "Renal cell carcinoma"
            ],
            [
              "",
              "Phaeochromocytoma"
            ],
            [
              "",
              "Islet cell carcinoma"
            ],
            [
              "",
              "Epididymal cysts/adenomas"
            ],
            [
              "",
              "Visceral cysts"
            ]
          ]
        }
      },
      {
        "title": "Vascular Syndromes",
        "icon": "water_drop",
        "type": "plain_text",
        "layout": "full_width",
        "color_theme": "blue",
        "content": "Sturge–Weber and Wyburn–Mason syndrome: These rare syndromes of vascular abnormalities differ from the ‘true’ phakomatoses in that they occur sporadically and the tumours (or AVM for Wyburn–Mason) are present from birth."
      },
      {
        "title": "Table 18.51: Features of Sturge–Weber Syndrome",
        "icon": "face",
        "type": "table",
        "layout": "half_width",
        "color_theme": "blue",
        "content": {
          "headers": [
            "Ocular Features",
            "Systemic Features"
          ],
          "rows": [
            [
              "Episcleral haemangioma",
              "Naevus flammeus of the face (port-wine stain)"
            ],
            [
              "Ciliary body/iris haemangioma",
              "CNS haemangioma"
            ],
            [
              "Choroidal haemangioma (diffuse)",
              ""
            ],
            [
              "Glaucoma",
              ""
            ]
          ]
        }
      },
      {
        "title": "Table 18.52: Features of Wyburn–Mason Syndrome",
        "icon": "hub",
        "type": "table",
        "layout": "half_width",
        "color_theme": "blue",
        "content": {
          "headers": [
            "Ocular Features",
            "Systemic Features"
          ],
          "rows": [
            [
              "Retinal AVM",
              "Cerebral/brainstem AVM"
            ],
            [
              "Orbital/periorbital AVM",
              ""
            ]
          ]
        }
      },
      {
        "title": "Source Metadata",
        "icon": "menu_book",
        "type": "key_point",
        "layout": "full_width",
        "color_theme": "blue",
        "content": [
          "Chapter 18: Paediatric Ophthalmology",
          "Pages 919 - 920",
          "Topic: PhAKOMATOSES"
        ]
      }
    ]
  },
  "chapterId": "pediatric",
  "seqId": 47
}